CCP
TMO icon

Cardan Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Cardan Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$403K Buy
705
+47
+7% +$25.8K 0.05% 170
2021
Q2 		$332K Buy
658
+46
+8% +$21.7K 0.04% 198
2021
Q1 		$279K Hold
612
– – 0.03% 191
2020
Q4 		$285K Sell
612
-3
-0.5% -$1.41K 0.04% 188
2020
Q3 		$272K Hold
615
– – 0.04% 192
2020
Q2 		$223K Buy
+615
New +$206K 0.03% 210

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cardan Capital Partners's TMO Position: Q3 2021 in Review

Cardan Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 7.1% in Q3 2021, buying an estimated $25.8K and bringing the position to 705 shares worth $403K. The position accounts for 0.05% of the portfolio, ranked #170.

Cardan Capital Partners first reported a position in TMO in Q2 2020 and has held it in 6 quarters since. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Cardan Capital Partners held 705 shares of Thermo Fisher Scientific worth $403K as of Q3 2021.
  • Cardan Capital Partners bought 47 Thermo Fisher Scientific shares in Q3 2021, an estimated $25.8K.
  • Thermo Fisher Scientific made up 0.05% of Cardan Capital Partners's portfolio in Q3 2021, its #170 holding.
  • Cardan Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 6 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.